CL King Starts Pacific Biosciences of California (PACB) at Buy
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.36 -2.86%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 17
Join SI Premium – FREE
CL King initiated coverage on Pacific Biosciences of California (NASDAQ: PACB) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $8.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Assembly Biosciences (ASMB) at Buy
- Rosenblatt Starts Booking Holdings (BKNG) at Buy
- Rosenblatt Starts Uber Inc. (UBER) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CL KingSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
